Nisha T., 39, Kenya

Assuta Medical Center, Israel
Oncology, Tumor Surgery

Nisha T. lives with her husband Rajesh and two children in Nakuru, Kenya. In August 2011 during a medical trip to India, an abdominal ultrasound detected the presence of a well-defined, solid lesion* in her lower left kidney. Her Indian doctor suggested further investigation or a biopsy. Nisha ignored the advice for a few months until, back in Kenya, she read that this type of lesion carries a high chance of malignancy.

Two Israeli friends living in Nakuru referred her to a urologist, Dr. Zwika Luttwak, at Assuta Medical Center in Tel Aviv. Dr. Luttwak suggested she undergo an MRI scan in Nairobi, which revealed the need to have the lesion removed.

Nisha traveled to Assuta in March 2012 with a friend, was re-diagnosed. Under the direction of chief surgeon Dr. Andrei Nadu, she underwent a robotics-assisted laparoscopy (partial nephrectomy), where the non-malignant tumor was removed. The treatment was successful, and Nisha returned home ten days later, with no further need for chemotherapy or radiation treatments.

"I hold some very fond memories for Dr. Luttwak, Assuta Hospital, and for Israel as a country in general. After all it's like having a new life," said Nisha. "One reason I chose Israel was that I wanted to have my surgery done with latest technology [robotics-assisted laparoscopy], this was at that time only available in a few countries and one of them was Assuta in Israel."

"The patient's official diagnosis was "incidental 4cm, enhancing solid mass in the left kidney, the pathological examination demonstrated papillary type 1 type renal cell carcinoma, Fuhrman grade 1-2, surgical margin free of tumor, T1aNoMo, completely excised."

I hold some very fond memories for Dr. Luttwak, Assuta Hospital, and for Israel as a country in general, after all it's like having a new life. Another reason I chose Israel was that I wanted to have my surgery done with latest technology, this was only available in a few countries...

Last updated on 5 December 2016